Companion Diagnostics Market Worth $9.9 Billion by 2026 - Global Trends, Share Analysis, Leading Players, Business Opportunities
According to the new market research report "Companion Diagnostics Market by Product (Assays, Kits, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Blood, Lung, Colorectal Cancer, Neurology Diseases), End User (Pharma Companies, CROs), Region - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6%.
View full press release